Gene expression meta-analysis of Parkinson's disease and its relationship with Alzheimer's disease

scientific article published on 28 February 2019

Gene expression meta-analysis of Parkinson's disease and its relationship with Alzheimer's disease is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P6179Dimensions Publication ID1112465075
P356DOI10.1186/S13041-019-0436-5
P932PMC publication ID6396547
P698PubMed publication ID30819229

P50authorDiego AlbaniQ56380921
Xinzhong LiQ60973676
Jack KellyQ92017974
P2093author name stringCamille Carroll
Rana Moyeed
P2860cites workMicroarrays, deep sequencing and the true measure of the transcriptomeQ21245309
Cytoscape: a software environment for integrated models of biomolecular interaction networksQ24515682
PGC-1α, a potential therapeutic target for early intervention in Parkinson's diseaseQ24597726
Molecular genetics of early-onset Alzheimer's disease revisitedQ26750717
Neuroinflammation in Parkinson's disease and its potential as therapeutic targetQ26783305
Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.Q27304699
Staging of brain pathology related to sporadic Parkinson's diseaseQ28131702
REST and stress resistance in ageing and Alzheimer's diseaseQ28236857
Syndromic parkinsonism and dementia associated with OPA1 missense mutationsQ28259640
affy--analysis of Affymetrix GeneChip data at the probe levelQ29547353
Adjusting batch effects in microarray expression data using empirical Bayes methodsQ29614937
limma powers differential expression analyses for RNA-sequencing and microarray studiesQ29617988
Chronic inflammation (inflammaging) and its potential contribution to age-associated diseasesQ34040980
Systems-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanismsQ34109658
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer diseaseQ34493731
The genetic background of Parkinson's disease: current progress and future prospectsQ34513714
Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.Q35675907
Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteinsQ35691151
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease.Q51923343
A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5).Q54628741
Integrated Analysis and Identification of Novel Biomarkers in Parkinson's Disease.Q55497257
Prevalence of Parkinson's disease across North America.Q55640768
Sex-Specific Transcriptome Differences in Substantia Nigra Tissue: A Meta-Analysis of Parkinson's Disease DataQ56381130
Tau Pathology in Parkinson's DiseaseQ58586744
Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson diseaseQ35899904
Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression.Q36128123
Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson's disease: a comparison of 33 human and animal studies.Q36321061
A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx ProjectQ36362149
Complexity of dopamine metabolism.Q36958208
Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementiaQ37010486
α-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responsesQ37390499
Causal analysis approaches in Ingenuity Pathway AnalysisQ37592031
Systematic analysis of microarray datasets to identify Parkinson's disease‑associated pathways and genesQ37722131
14-3-3 proteins in neurological disorders.Q38024792
CDK5 and MAPT Gene Expression in Alzheimer's Disease Brain SamplesQ38656657
Sirtuins as modifiers of Parkinson's disease pathologyQ38893382
Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative DisordersQ38954686
Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsyQ39327310
Alteration of NRSF expression exacerbating 1-methyl-4-phenyl-pyridinium ion-induced cell death of SH-SY5Y cellsQ39821107
Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's diseaseQ40017984
Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's diseaseQ42134488
Discovery of Novel Biomarkers for Alzheimer's Disease from BloodQ42433419
A review of genome-wide transcriptomics studies in Parkinson's diseaseQ42778276
Structure, function, involvement in diseases and targeting of 14-3-3 proteins: an updateQ46373465
Dementia Predictors in Parkinson Disease: A Validation StudyQ47788122
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci.Q47823702
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesCytoscapeQ3699942
limmaQ112236343
affyQ113334509
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
Parkinson's diseaseQ11085
Parkinson’s DiseaseQ39074077
P304page(s)16
P577publication date2019-02-28
P1433published inMolecular BrainQ6895938
P1476titleGene expression meta-analysis of Parkinson's disease and its relationship with Alzheimer's disease
P478volume12

Reverse relations

cites work (P2860)
Q90604684Genetic networks in Parkinson's and Alzheimer's disease
Q102152196Spen modulates lipid droplet content in adult Drosophila glial cells and protects against paraquat toxicity
Q90091679Transcriptomic signatures of brain regional vulnerability to Parkinson's disease

Search more.